drugset / Trial / NCT07414784
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
NaSingle-groupOpen-labelTreatment
Summary
This Study of ABBV-295 subcutaneous injections will assess pharmacokinetics and adverse events in healthy adult women participants with overweight or obesity taking oral contraceptives.
Timeline
- Start
- 2026-02-11
- Primary completion
- 2026-08-04
- Completion
- 2026-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-295 | Unknown | — | Subcutaneous |
| Subject | Levonorgestrel | Small molecule | — | Oral |
| Subject | ethinyl estradiol | Small molecule | — | Oral |
Indications
No indication recorded.